iECURE, inc.

iECURE, inc.

Biotechnology

Philadelphia, PA 3,358 followers

Mutation-Agnostic in vivo Gene Insertion

About us

iECURE is a clinical-stage biotechnology company focused on delivering cures and transforming the lives of patients with devastating liver disorders, utilizing new advancements in genetic medicine. We are advancing our pipeline in close partnership with the world-class translational engine at the University of Pennsylvania’s Gene Therapy Program. Using in vivo editing, our methods focus on inserting functioning genes into patients’ genomes, which offers long-term, stable expression of those genes. With our team’s proven track record, as well as the University of Pennsylvania’s deep expertise and translational genetic medicine engine, reversing the course of these devastating diseases is now within reach.

Industry
Biotechnology
Company size
11-50 employees
Headquarters
Philadelphia, PA
Type
Privately Held

Locations

Employees at iECURE, inc.

Updates

Similar pages

Browse jobs

Funding